Anderlove Fequiere-smith, LPC | |
135 Stoddard Dr Apt 223, Meriden, CT 06451-3752 | |
(515) 164-4474 | |
Not Available |
Full Name | Anderlove Fequiere-smith |
---|---|
Gender | Female |
Speciality | Counselor - Professional |
Location | 135 Stoddard Dr Apt 223, Meriden, Connecticut |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073294484 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YP2500X | Counselor - Professional | 6560 (Connecticut) | Secondary |
101YP2500X | Counselor - Professional | 6743 (Connecticut) | Primary |
Mailing Address | Practice Location Address |
---|---|
Anderlove Fequiere-smith, LPC 135 Stoddard Dr Apt 223, Meriden, CT 06451-3752 Ph: (515) 164-4474 | Anderlove Fequiere-smith, LPC 135 Stoddard Dr Apt 223, Meriden, CT 06451-3752 Ph: (515) 164-4474 |
News Archive
Russian scientists investigated the role of opioid receptors in protecting the heart from coronary disease: the lack of its blood supply.
Nurses sleep nearly an hour and a half less before work days compared to days off, which hurts patient care and safety, finds a new study by researchers at NYU Rory Meyers College of Nursing. The findings are published in Sleep Health, the journal of the National Sleep Foundation.
A researcher at the University of Pittsburgh School of Medicine, in collaboration with scientists from the National Institutes of Health, has discovered that the deadly plaques of Alzheimer's disease interact with certain cellular proteins to inhibit normal signals that maintain blood flow to the brain.
The Harvard Clinical Research Institute (HCRI) announced today that the enrollment phase of the DAPT Study has been successfully completed. The DAPT Study is a four-year clinical trial investigating the duration of dual antiplatelet therapy (DAPT, the combination of aspirin and a thienopyridine/antiplatelet medication to reduce the risk of blood clots) following drug-eluting stent implantations.
Antares Pharma, Inc. today reported financial and operating results for the first quarter ended March 31, 2011.
› Verified 7 days ago
Ms. Chris Ellen Salonia, Counselor Medicare: Not Enrolled in Medicare Practice Location: 82 Smithfield Ave, Meriden, CT 06451 Phone: 203-235-4864 | |
Mr. Jose Maria Benzo Jr., M.S Counselor Medicare: Not Enrolled in Medicare Practice Location: 883 Paddock Ave, Meriden, CT 06450 Phone: 203-630-5305 | |
Mr. Thomas Alfred Thurber, LCSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 391 Broad St, Meriden, CT 06450 Phone: 203-634-3546 Fax: 203-237-9679 | |
Mr. Michael Anthony Burke, LADC, LMSW, CCDP-D, Counselor Medicare: Not Enrolled in Medicare Practice Location: 883 Paddock Ave, Meriden, CT 06450 Phone: 860-630-5346 | |
Mrs. Christina Marie Hadlock, LPC Counselor Medicare: Medicare Enrolled Practice Location: 883 Paddock Ave, Meriden, CT 06450 Phone: 203-988-1602 | |
Stephen Falconieri, LPC,LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 12 Curtis St, Meriden, CT 06450 Phone: 203-228-2606 |